BioCentury
ARTICLE | Clinical News

Tykerb: Phase III data

May 6, 2013 7:00 AM UTC

GlaxoSmithKline disclosed in its 1Q13 earnings that the double-blind, international Phase III LOGiC trial in about 545 patients with locally advanced, unresectable or metastatic HER2-positive gastric ...